Follow-The-Filings

Security · featured owners

PACB

Pacific Biosciences Calif In COM Equity as of 2026 Q2 among managers we track

  • 3 Owners
  • Max 0.3%
  • $50M
  • 3 reduce

Who owns this now

Largest portfolio weights among featured holders · max 0.3% (Cathie Wood - Ark Investm...) · not free-float ownership

  1. Cathie Wood reduce 0.3%

holders

sorted by % of portfolio · long equity only · open a manager for their book

history
Cathie Wood - Ark Investment Management 2026 Q2 0.3% Reduce −17.9% 29,781,416 $50M hist
Farallon Capital Management 2026 Q2 0% Reduce −89.5% 14,200 $24K hist
Murray Stahl - Horizon Kinetics Asset Management 2026 Q2 0% Reduce −4.6% 10,068 $17K hist

3 current · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue — — —
Gross profit $52.78M $37.28M $45.78M
Gross margin — — —
Net income -$306.74M -$309.85M -$546.38M
Net margin — — —

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $742.05M $495.68M $375.05M
Total non-current assets * $1B $764.77M $409.03M
Total assets $1.75B $1.26B $784.08M
Total current liabilities $95.03M $66.3M $72.83M
Total non-current liabilities * $949.68M $687.55M $705.9M
Total equity $701.3M $506.59M $5.35M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$259.17M -$206.06M -$111.21M
Cash from investing $4.6M $124M $115.45M
Cash from financing $108.89M -$42.99M $3.43M
Net change in cash -$145.68M -$125.04M $7.67M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders